Norvium Bioscience Drug Patent Portfolio
Norvium Bioscience owns 4 orange book drugs protected by 7 US patents Given below is the list of Norvium Bioscience's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7141237 | Pharmaceutical foam | 03 Feb, 2024 | Expired |
| US7374747 | Pharmaceutical foam | 23 Jan, 2024 | Expired |
| US7553835 | Topical antifungal composition | 19 Oct, 2018 | Expired |
| US8026238 | Topical antifungal composition | 19 Oct, 2018 | Expired |
| US6126920 | Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition | 01 Mar, 2016 | Expired |
| US5733569 | Galenic compositions comprising calcitonin and their use | 31 Mar, 2015 | Expired |
| US5759565 | Galenic compositions comprising calcitonin and their use | 31 Mar, 2015 | Expired |
Latest Legal Activities on Norvium Bioscience's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Norvium Bioscience.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 30 Oct, 2023 | US8026238 |
|
Maintenance Fee Reminder Mailed
Critical
| 15 May, 2023 | US8026238 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 22 Oct, 2019 | US7374747 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Mar, 2019 | US8026238 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 13 Apr, 2018 | US7141237 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 14 Nov, 2016 | US8026238 |
|
Email Notification
Critical
| 14 Nov, 2016 | US8026238 |
|
Correspondence Address Change
Critical
| 10 Nov, 2016 | US8026238 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 01 Oct, 2013 | US8026238 |
|
Email Notification
Critical
| 01 Oct, 2013 | US8026238 |
|
Correspondence Address Change
Critical
| 30 Sep, 2013 | US8026238 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 17 Jan, 2012 | US7374747 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 27 Sep, 2011 | US8026238 |
|
Recordation of Patent Grant Mailed
Critical
| 27 Sep, 2011 | US8026238 |
|
Issue Notification Mailed
Critical
| 07 Sep, 2011 | US8026238 |
Norvium Bioscience's Drug Patent Litigations
Norvium Bioscience's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on May 23, 1994, against patent number US5759565. The petitioner , challenged the validity of this patent, with AZRIA et al as the respondent. Click below to track the latest information on how companies are challenging Norvium Bioscience's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US5759565 | May, 1994 |
Decision
(25 Aug, 1997)
| AZRIA et al | |
Norvium Bioscience's Family Patents
Norvium Bioscience Drug List
Given below is the complete list of Norvium Bioscience's drugs and the patents protecting them.
1. Evoclin
Evoclin is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7141237 | Pharmaceutical foam |
03 Feb, 2024
(1 year, 7 months ago)
| Expired |
| US7374747 | Pharmaceutical foam |
23 Jan, 2024
(1 year, 7 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Evoclin's drug page
2. Extina
Extina is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7553835 | Topical antifungal composition |
19 Oct, 2018
(6 years ago)
| Expired |
| US8026238 | Topical antifungal composition |
19 Oct, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Extina's drug page
3. Miacalcin
Miacalcin is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5733569 | Galenic compositions comprising calcitonin and their use |
31 Mar, 2015
(10 years ago)
| Expired |
| US5759565 | Galenic compositions comprising calcitonin and their use |
31 Mar, 2015
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Miacalcin's drug page
4. Olux
Olux is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6126920 | Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition |
01 Mar, 2016
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Olux's drug page